AILERON THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.76 USD | -1.57% |
|
-24.80% | +23.34% |
| 05-03 | Aileron Therapeutics Closes Direct Offering of Shares, Warrants | MT |
| 05-01 | Transcript : Aileron Therapeutics, Inc. - Special Call |
Chart calendar Aileron Therapeutics, Inc.
ae84ebe56755a327a0c8ede1eec0.ezXxmb0VpYNrZBTtg35Mk0WoS8yCwXOV0lKL4v98qCg.JEK289ZA7OolK22ptkgUoQr4KbvJsyXztjbuo5dNzWpOdqb7_3L_2w8BUQ~0aee51339d402f72195460ee6eaabe3a
Upcoming events on Aileron Therapeutics, Inc.
Past events on Aileron Therapeutics, Inc.
| 2024-05-01 09:00 | LTI-03 Phase 1b Clinical Trial Results Call |
| 2024-04-15 17:20 | Q4 2023 Earnings Release |
| 2024-03-19 15:00 | ROTH Conference |
| 2024-02-28 08:30 | Annual General Meeting |
| 2024-02-15 16:30 | Investor Meeting - Key Opinion Leader |
| 2023-10-31 13:30 | Business Update Call |
| 2022-11-01 08:15 | Q3 2022 Earnings Release |
| 2022-10-01 06:40 | European Society for Dermatological Research Meeting - Abstract Number : 549 |
| 2022-09-29 15:30 | Ladenburg Thalmann Healthcare Conference |
| 2022-09-12 07:00 | H.C. Wainwright Global Investment Conference |
| 2022-08-15 16:15 | Interim 2022 Earnings Release |
| 2022-07-11 | William Blair Biotech Focus Conference - Fireside Chat |
| 2022-06-29 08:00 | Phase 1b Chemoprotection Trial Of ALRN-6924 Update Call |
| 2022-06-15 08:30 | Annual General Meeting |
| 2022-05-25 13:30 | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-19 16:00 | Investor Meeting - Key Opinion Leader |
| 2022-05-19 11:45 | Society for Investigative Dermatology Meeting |
| 2022-05-05 16:15 | Q1 2022 Earnings Release |
| 2022-03-28 16:20 | FY 2021 Earnings Release |
| 2022-03-28 09:00 | Maxim Group Virtual Growth Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -29,8 -27,8 -7.34% | -20,3 -22,7 10.4% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -30,0 -30,6 2.14% | -20,5 -21,5 4.52% | -26,6 -27,3 2.63% | -27,6 -29,1 4.89% | -16,3 -12,2 -33.84% | -23,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -29,4 -30,2 2.65% | -21,2 -20,5 -3.4% | -26,2 -26,8 2.35% | -27,3 -28,6 4.44% | -15,7 -11,4 -37.77% | -23,1 |
|
Net income Million USD | Released Forecast Spread | -29,4 -30,1 2.46% | -21,2 -20,7 -2.22% | -26,2 -26,9 2.6% | -27,3 -28,9 5.28% | -15,7 -11,4 -37.77% | -23,1 |
|
EPS USD | Released Forecast Spread | -24,0 -24,6 2.44% | -12,2 -12,0 -1.67% | -5,80 -6,00 3.33% | -6,02 -6,40 5.94% | -3,42 -2,01 -70.15% | -3,62 |
| Announcement Date | 30/03/20 | 24/03/21 | 28/03/22 | 20/03/23 | 15/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,82 -7,54 9.54% | -8,42 -7,04 -19.55% | -8,04 -8,63 6.8% | -6,48 -7,22 10.2% | -4,70 -6,13 23.22% | -5,01 -4,77 -5.1% | -2,08 -3,90 46.67% | -7,29 -3,18 -129.61% | -5,02 | -5,55 | -6,17 | -6,74 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,80 -7,43 8.49% | -8,42 -6,95 -21.14% | -7,99 -8,83 9.52% | -6,37 -6,76 5.76% | -4,55 -5,82 21.82% | -4,78 -4,76 -0.48% | -1,79 -3,82 53.16% | -7,34 -3,03 -142.53% | -5,02 | -5,55 | -6,07 | -6,42 |
|
Net income Million USD | Released Forecast Spread | -6,80 -7,50 9.3% | -8,42 -7,04 -19.69% | -7,99 -8,62 7.32% | -6,37 -7,20 11.53% | -4,55 -6,07 25.11% | -4,78 -4,76 -0.48% | -1,79 -3,82 53.16% | -7,34 -3,03 -142.53% | -5,02 | -5,55 | -6,07 | -6,42 |
|
EPS USD | Released Forecast Spread | -1,60 -1,60 0% | -1,80 -1,60 -12.5% | -1,80 -1,90 5.26% | -1,40 -1,60 12.5% | -1,02 -1,20 15% | -1,05 -0,60 -75% | -0,39 -0,40 2.5% | -1,54 -0,16 -862.5% | -1,02 | -1,13 | -0,82 | -0,65 |
| Announcement Date | 28/03/22 | 05/05/22 | 15/08/22 | 01/11/22 | 20/03/23 | 08/05/23 | 11/08/23 | 15/04/24 | - | - | - | - |
More events
Past sector events for Aileron Therapeutics, Inc.
| 2024-05-03 07:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-02 16:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 2024-05-02 11:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALRN Stock
- Calendar Aileron Therapeutics, Inc.
